Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 271-280 of 314 for infectious diseases

Edit search filters
  1. Early Identification of Pulmonary Coccidioidomycosis

    Scottsdale/Phoenix, AZ

  2. Registry of Patients Treated With Systemic Mold-Active Triazoles

    Scottsdale/Phoenix, AZ

  3. A Study to Evaluate the Performance of Chembio Diagnostics Systems, Inc. DPP® Zika IgM Assay System With Fingerstick Whole Blood (MVSS CBD002-18 PRO)

    Rochester, MN

  4. A Study to Evaluate the Relationship Between Vaginal and Lower Urinary Tract Microbiomes and Infection After A Hysterectomy

    Rochester, MN

  5. Detection of Infection in Arthroplasty

    Rochester, MN

  6. Registry of Patients Treated With Systemic Mold-Active Triazoles

    Rochester, MN

  7. Analysis of Blood and Urine for Microbial Pathogen Discovery and Undiagnosed Infection

    Rochester, MN

  8. A Study to Evaluate Clinical Performance of the Aptima® CMV Quant Assay on the Panther® System

    Rochester, MN

  9. A Study of the Quantiferon CMV Blood Test to Predict the Risk of CMV Returning After Treatment of the Disease in Solid Organ Transplant Recipients

    Rochester, MN

  10. Characterizing HIV-related Diastolic Dysfunction

    Rochester, MN

.

Mayo Clinic Footer